Noile-Immune Biotech
Tokyo
About Noile-Immune Biotech
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.6M
- Funding stage: IPO
- Last round: Series C (Mar 2021)
- Ticker: tyo:4893
- Website: noile-immune.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Oncology
Canonical: https://fsome.com/organization/noile-immune-biotech-15797 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.